HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ashcroft, F M Articles by Harrison, D E Search for Related Content PubMed PubMed Citation Articles by Ashcroft, F M Articles by Harrison, D E

Department of Physiology, Oxford.

1. The effects of the insulin secretagogue 2-ketoisocaproate, and of arginine, on insulin release, intracellular adenosine triphosphate (ATP) concentration and the activity of single K channels in cell-attached membrane patches have been studied in primary cultures of beta-cells from adult rat islets of Langerhans. 2. Insulin secretion was significantly increased by 2-ketoisocaproate (20 mM). The time course of this release was biphasic. Arginine (20 mM) did not stimulate insulin secretion. 3. In the absence of 2-ketoisocaproate (or arginine), two kinds of K channel were regularly observed in cell-attached membrane patches held at the cell resting potential: a channel of approximately 20 pS conductance and a channel of 50 pS conductance ([K]o = 140 mM, room temperature). 4. Addition of 2-ketoisocaproate (20 mM) to the bath suppressed the activity of the 50 pS channel and initiated action potentials. Arginine (20 mM) was without effect. 5. The intracellular concentration of ATP was increased significantly by 2-ketoisocaproate (20 mM) but not by arginine (20 mM). 6. It is suggested that, like glucose, 2-ketoisocaproate depolarizes the beta-cell and mediates insulin secretion by reducing the open probability of the 50 pS K channel. The results are also consistent with the idea that both secretagogues inhibit this channel by increasing the cytoplasmic concentration of ATP.

This article has been cited by other articles:

				S Patterson, P R Flatt, L Brennan, P Newsholme, and N H McClenaghan Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic {beta}-cell glucose metabolism and insulin secretion. J. Endocrinol., May 1, 2006; 189(2): 301 - 310. [Abstract] [Full Text] [PDF]

				H. Heissig, K. A. Urban, K. Hastedt, B. J. Zunkler, and U. Panten Mechanism of the Insulin-Releasing Action of {alpha}-Ketoisocaproate and Related {alpha}-Keto Acid Anions Mol. Pharmacol., October 1, 2005; 68(4): 1097 - 1105. [Abstract] [Full Text] [PDF]

				M. Brissova, M. Shiota, W. E. Nicholson, M. Gannon, S. M. Knobel, D. W. Piston, C. V. E. Wright, and A. C. Powers Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion J. Biol. Chem., March 22, 2002; 277(13): 11225 - 11232. [Abstract] [Full Text] [PDF]

				R. Branstrom, S. Efendic, P.-O. Berggren, and O. Larsson Direct Inhibition of the Pancreatic beta -Cell ATP-regulated Potassium Channel by alpha -Ketoisocaproate J. Biol. Chem., June 5, 1998; 273(23): 14113 - 14118. [Abstract] [Full Text] [PDF]

				T. J. Ribar, C.-R. Jan, G. J. Augustine, and A. R. Means Defective Glycolysis and Calcium Signaling Underlie Impaired Insulin Secretion in a Transgenic Mouse J. Biol. Chem., December 1, 1995; 270(48): 28688 - 28695. [Abstract] [Full Text] [PDF]